We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

90 hedge funds and large institutions have $108M invested in Applied Genetic Technologies Corporation in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

342% more call options, than puts

Call options by funds: $468K | Put options by funds: $106K

48% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 25

7% more capital invested

Capital invested by funds: $101M → $108M (+$7.32M)

5% less funds holding

Funds holding: 9590 (-5)

20% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 20

Holders
90
Holders Change
-5
Holders Change %
-5.26%
% of All Funds
2.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
37
Reduced
25
Closed
20
Calls
$468K
Puts
$106K
Net Calls
+$362K
Net Calls Change
-$131K
Name Holding Trade Value Shares
Change
Change in
Stake
IVM
1
InterWest Venture Management
California
$13.6M +$13.1M +1,452,216 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$10.4M +$224K +24,864 +2%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$6.7M +$507K +56,301 +9%
NI
4
Numeric Investors
Massachusetts
$5.3M -$509K -56,548 -9%
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.01M +$359K +39,894 +8%
AL
6
AJO LP
Pennsylvania
$4.39M +$1.66M +184,533 +65%
Millennium Management
7
Millennium Management
New York
$4.12M +$819K +90,908 +26%
BFA
8
BlackRock Fund Advisors
California
$3.85M -$1.64M -181,823 -31%
EMFAT
9
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.14M -$728K -80,837 -19%
BIT
10
BlackRock Institutional Trust
California
$3.09M +$456K +50,607 +18%
PI
11
Putnam Investments
Massachusetts
$2.88M -$236K -26,233 -8%
State Street
12
State Street
Massachusetts
$2.81M +$49.1K +5,452 +2%
DCM
13
DAFNA Capital Management
California
$2.68M +$414K +46,000 +19%
EA
14
Emerald Advisers
Pennsylvania
$2.65M -$58.5K -6,495 -2%
EAM
15
Eventide Asset Management
Massachusetts
$2.61M
PAM
16
Panagora Asset Management
Massachusetts
$2.13M +$287K +31,847 +16%
AGA
17
Altrinsic Global Advisors
Connecticut
$2.05M
AQR Capital Management
18
AQR Capital Management
Connecticut
$2M +$1.03M +114,034 +114%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$1.78M
OAM
20
Oxford Asset Management
United Kingdom
$1.74M -$13.4K -1,488 -0.8%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$1.37M +$153K +16,942 +13%
Northern Trust
22
Northern Trust
Illinois
$1.24M -$43.8K -4,865 -4%
Morgan Stanley
23
Morgan Stanley
New York
$1.24M +$705K +78,270 +145%
Prudential Financial
24
Prudential Financial
New Jersey
$1.17M +$934K +103,700 +487%
GC
25
Globeflex Capital
California
$1.16M +$485K +53,900 +76%

AGTC Hedge Fund Activity: Q4 2016 in Review

90 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2016, worth a combined $108M — up 7.2% from $101M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of AGTC and 16 opened new positions — a net loss of 4 holders — while 25 trimmed existing stakes and 37 added.

The largest buyer was AJO LP, adding an estimated $1.66M. The largest seller was Perceptive Advisors, cutting an estimated $3.38M.

  • 90 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2016, down from 95 in Q3 2016.
  • Funds reported $108M of Applied Genetic Technologies Corporation stock for Q4 2016, up 7.2% quarter-over-quarter.
  • 16 funds opened new Applied Genetic Technologies Corporation positions in Q4 2016 and 20 closed out, a net change of -4 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q4 2016 was AJO LP, an estimated $1.66M added.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2016 was Perceptive Advisors, an estimated $3.38M sold.

Based on aggregated 13F filings for Q4 2016.